KZIA
Kazia Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · AU
$12.31
+1.23%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.49x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 1.53x
Liquidity & coverage
- Current ratio
- 2.87x
- Quick ratio
- 2.87x
- Cash ratio
- 2.85x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $32.8M
Cash & dividend
- FCF / debt
- -167.47x
- Cash flow / debt
- -209.43x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025